Central Securities Corp.
New York Stock Exchange AmericanCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- John C. Hill
- Full Time Employees
- 6
- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 630 Fifth Avenue New York City NY United States of America 10111
- IPO Date
- Mar 17, 1980
- CIK
- 0000018748
- Website
- centralsecurities.com
- Similar Companies
- Business
- Central Securities Corporation (NYSE American: CET) operates as a non-diversified closed-end management investment company with a primary objective of long-term growth of capital; income from investments serves as a secondary consideration. Founded on October 1, 1929, and headquartered at 630 Fifth Avenue in New York City, the company invests principally in domestic public equity securities it deems undervalued with growth potential, alongside bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options, real estate, and short-term obligations of governments, banks, and corporations; it maintains a concentrated portfolio with low turnover, approximately 8% in 2024, targeting superior returns relative to broad market indices while preserving capital amid inflation. The firm, managed internally by a small team including President and CEO John C. Hill, caters to individual and institutional investors seeking capital appreciation through active value-oriented strategies focused on the U.S. markets. Recent developments include the release of its Report to Stockholders for the nine months ended September 30, 2025, showing net assets of $1.775 billion, up from $1.594 billion a year earlier, with net assets per share rising to $61.39 from $56.17 amid an increase in outstanding shares to 28.91 million; additionally, CEO John C. Hill purchased 100 shares on November 7, 2025, and the company declared a year-end distribution payable December 19, 2025.
Central Securities Corporation Declares Dividend
Invitation to presentation of BioArctic's first quarter report for January - March 2026 on May 20 at 9:30 a.m. CET
Galapagos Reports First Quarter 2026 Financial Results and Provides Business Update
Zealand Pharma conference call on May 7 at 2pm CET (8am ET) to present first quarter 2026 financial results
Central Securities Corporation Releases Report to Stockholders
BNP PARIBAS CONFIRMS ITS CET1 RATIO TRAJECTORY FOLLOWING THE UPDATE OF THE ECB O-SII FRAMEWORK
Publication of the Q1 2026 financial results on Tuesday, May 5, 2026, after market close
Invitation to presentation of the interim report January-March 2026 for Truecaller AB (publ)
Coface SA: Combined Shareholders' Meeting on Tuesday, May 19, 2026 at 2:00 p.m. CET
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases
Galapagos Publishes 2025 Annual Report and Announces Annual and Extraordinary Shareholders' Meetings
Invitation to Alfa Laval's first quarter conference call
Correction of the publication from 20. Mar 2026/ 09:15 CET/CEST - Deutsche Lufthansa AG: Mr Carsten Spohr, Acquisition
Norsk Hydro: Potential impact on Qatalum aluminium production
Central Securities Corporation Releases Annual Report to Stockholders for the Year Ended December 31, 2025
BW Offshore: Invitation to Q4 2025 Presentation 27 February
AMG Schedule for Fourth Quarter and Full Year 2025 Earnings Release
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
Publication of the 2025 annual financial results on Thursday, February 26, after market close
Invitation to presentation of BioArctic's fourth quarter report for October - December 2025 on February 18 at 9.30 a.m. CET